155 related articles for article (PubMed ID: 8837369)
1. Selection of subpopulations resistnat to amikacin and netilmicin of gentamicin-resistant clinical strains of Staphylococcus aureus and Staphylococcus epidermidis.
Torres García M; Tejedor Junco MT; González Martín M; González Lama Z
Zentralbl Bakteriol; 1996 Jun; 284(1):58-66. PubMed ID: 8837369
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic effect of aminoglycosides on staphylococci.
Isaksson B; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
DiPersio JR; Krafczyk TL
Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside resistance among blood culture isolates.
Huovinen P; Grönroos P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
J Clin Microbiol; 1984 Jul; 20(1):65-9. PubMed ID: 6378968
[TBL] [Abstract][Full Text] [Related]
5. pH modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-N-aminoglycoside acetyltransferase.
Culebras E; Martínez JL; Baquero F; Pérez-Díaz JC
J Antimicrob Chemother; 1996 May; 37(5):881-9. PubMed ID: 8737138
[TBL] [Abstract][Full Text] [Related]
6. Stability of aminoglycoside resistance in vitro in gentamicin-resistant Staphylococcus aureus.
Dixson S; Brumfitt W; Hamilton-Miller JM
J Hyg (Lond); 1984 Aug; 93(1):43-9. PubMed ID: 6747285
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of subpopulations of aminoglycoside- and vancomycin-resistant variants in Staphylococcus aureus and Staphylococcus epidermidis.
Rådberg G; Nilsson LE; Kihlström E; Maller R; Sörén L
J Antimicrob Chemother; 1992 Oct; 30(4):489-96. PubMed ID: 1490921
[TBL] [Abstract][Full Text] [Related]
8. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
9. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L
Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436
[TBL] [Abstract][Full Text] [Related]
10. [Synergy between tobramycin and netilmicin on three strains of methicillin and gentamicin resistant staphylococci (S. epidermidis, S. aureus)].
Ratovohery D; Assous MV; Gilly L; Brun T; Nevot P; Paul G
Ann Med Interne (Paris); 1994; 145(4):234-7. PubMed ID: 8092647
[TBL] [Abstract][Full Text] [Related]
11. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Juhlin I; Tunevall G
Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
Manoharan A; Lalitha MK; Jesudason MV
Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
Maes P
J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of netilmicin, gentamicin, and amikacin.
Kantor RJ; Norden CW
Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
[TBL] [Abstract][Full Text] [Related]
18. Reliability of a disk diffusion method using semiconfluent growth in the determination of aminoglycoside resistance.
Huovinen P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):153-7. PubMed ID: 3739715
[TBL] [Abstract][Full Text] [Related]
19. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Xiao Y; Hu Y
Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
[TBL] [Abstract][Full Text] [Related]
20. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
